Sanjay Gandhi to Quality of Life
This is a "connection" page, showing publications Sanjay Gandhi has written about Quality of Life.
Connection Strength
0.629
-
Silberstein SD, Cohen JM, Yang R, Gandhi SK, Du E, Jann AE, Marmura MJ. Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials. J Headache Pain. 2021 Jan 07; 22(1):2.
Score: 0.125
-
Lipton RB, Cohen JM, Gandhi SK, Yang R, Yeung PP, Buse DC. Effect of fremanezumab on quality of life and productivity in patients with chronic migraine. Neurology. 2020 08 18; 95(7):e878-e888.
Score: 0.121
-
McEvoy J, Gandhi SK, Rizio AA, Maher S, Kosinski M, Bjorner JB, Carroll B. Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia. Qual Life Res. 2019 Dec; 28(12):3303-3312.
Score: 0.113
-
Thorley EM, Iyer RG, Wicks P, Curran C, Gandhi SK, Abler V, Anderson KE, Carlozzi NE. Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States. Patient. 2018 10; 11(5):547-559.
Score: 0.107
-
Botros SM, Abramov Y, Miller JJ, Sand PK, Gandhi S, Nickolov A, Goldberg RP. Effect of parity on sexual function: an identical twin study. Obstet Gynecol. 2006 Apr; 107(4):765-70.
Score: 0.045
-
Abramov Y, Gandhi S, Goldberg RP, Botros SM, Kwon C, Sand PK. Site-specific rectocele repair compared with standard posterior colporrhaphy. Obstet Gynecol. 2005 Feb; 105(2):314-8.
Score: 0.041
-
Rosenfeld B, Roth AJ, Gandhi S, Penson D. Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psychooncology. 2004 Nov; 13(11):800-7.
Score: 0.041
-
Sung VW, Iyer RG, Gandhi SK, Shah-Manek B, DiBonaventura M, Abler V, Claassen DO. Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States. Curr Med Res Opin. 2018 04; 34(4):643-648.
Score: 0.026
-
Penson DF, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M. The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer. J Urol. 2005 Aug; 174(2):547-52; discussion 552.
Score: 0.011